Table 2

Characteristics of SSc patients
Characteristic Number (%)
Diffuse: limited skin involvement 20:73 (22:78)
Anti-centromere antibodies 30 (32)
Anti-topoisomerase antibodies 22 (24)
Anti-RNA polymerase III antibodies 3 (3)
Pathological cineradiography 70 (75)
Immunosuppressive therapy 36 (39)
Median (IQR)
Disease duration (years) 7 (2 to 13)

IQR: interquartile range.

Andréasson et al.

AndrĂ©asson et al. Arthritis Research & Therapy 2014 16:R46   doi:10.1186/ar4475

Open Data